Estradiol Valerate Injectable Recalled for Lack of Sterility Assurance
Talon Compounding Pharmacy is recalling Estradiol Valerate 10mg/mL Injectable due to lack of assurance of sterility. The product was distributed throughout the United States, including Washington, D.C. and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class II. Injectable drugs lacking sterility assurance present a significant risk of serious harm including infection, sepsis, and other serious adverse effects. The broad distribution across the United States and the injectable route of administration elevate the potential impact.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling Estradiol Valerate 10mg/mL in Ethyl Oleate 10mg/mL Injectable (Rx only) due to lack of assurance of sterility. The recalled product is identified as Lot 06232021:55 with a Beyond Use Date (BUD) of 12/20/2021.
The affected product was distributed throughout the United States, including Washington, D.C. and Puerto Rico. Patients who have received this medication should consult with their healthcare provider regarding appropriate follow-up care.
This is a Class II recall issued by the U.S. Food and Drug Administration. Consumers with questions or concerns about this recall should contact their pharmacist or healthcare provider.
The recalled product
- Product
- ESTRADIOL VALERATE 10MG/ML IN ETHYL OLEATE 10MG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- sterility-assurance
- contamination-risk
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 06232021:55 BUD: 12/20/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27